1. Adobor, H. (2012). Ethical issues in outsourcing: The case of contract medical research and the global pharmaceutical industry. Journal of Business Ethics, 105(2), 239–255.
2. Anson, B., Ma, J., & He, J. (2009). Identifying cardiotoxic compounds human iPS cell-derived cardiomyocytes (and other cell types) streamline quest for novel drug candidates. Genetic Engineering and Biotechnology News, 29(9), online.
3. Arfini, S., Bertolotti, T., & Magnani, L. (2019). Online communities as virtual cognitive niches. Synthese, 196(1), 377–397.
4. Avorn, J. (2006). “Dangerous deception”: Hiding the evidence of adverse drug effects. The New England Journal of Medicine, 355, 2169–2171.
5. Bennani, Y. L. (2011). Drug discovery in the next decade: Innovation needed ASAP. Drug Discovery Today, 16(17/18), 780–792.